SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

H.C. Wainwright cuts Atrium Therapeutics target to $20 from $25

Valid market news retained in the public archive without immediate LiveCast distribution.

RNA

Related stories